References
- Atlı Şekeroğlu Z, Afan F, Şekeroğlu V. (2012). Genotoxic and cytotoxic effects of doxycycline in cultured human peripheral blood lymphocytes. Drug Chem Toxicol 35:334–340
- Bartra J, Velero AL, del Curvillo A, et al. (2006). Interactions of the H1 antihistamines. J Investig Allergol Clin Immunol 16:29–36
- Bonassi S, Znaor A, Ceppi M, et al. (2007). An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625–631
- Börçek Kasurka C, Atlı Şekeroğlu Z, Şekeroğlu V. (2011). Evaluation of the genotoxicity and cytotoxicity of fexofenadine in cultured human peripheral blood lymphocytes. Toxicol In Vitro 25:1480–1484
- Brambilla G, Mattioli F, Robbiano L, Martelli A. (2011). Genotoxicity and carcinogenicity studies of antihistamines. Arch Toxicol 85:1173–1187
- Brambilla G, Martelli A. (2009). Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals. Mutat Res 681:209–229
- Carrano AV, Natarajan AT. (1988). Consideration for population monitoring using cytogenetic techniques. Mutat Res 204:379–406
- Chen JS, Lin SY, Tso WL, et al. (2006). Checkpoint kinase 1-mediated phosphorylation of cdc25C and bad proteins are involved in antitumor effects ofloratadine-induced G2/M phase cell-cycle arrest and apoptosis. Mol Carcinogen 45:461–478
- Clissold SP, Sorkin EM, Goa KL. (1989). Loratadine, a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 37:42–57
- Derman EW, Hawarden D, Schwellnus MP. (2010). Allergic rhinoconjunctivitis in athletes-mechanisms of impaired performance and implications for management. Current Allergy Clin Immunol 23:59–62
- Eastmond DA, Tucker JD. (1989). Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an anti-kinetochore antibody. Environ Mol Mutagen 13:34–43
- Evans HJ. (1984). Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. In: Kilbey BJ, Legator M, Nichols W, Ramel C, eds. Handbook of mutagenicity test procedures. Amsterdam: Elsevier Science, 405–427
- Fenech M. (2000). The in vitro micronucleus technique. Mutat Res 455:81–95
- Food and Drug Administration (2000). Product information of CLARITIN® brand of loratadine. Available from: http://www.fda.gov/ohrms/dockets/ac/01/briefing/3737b_12_label-claritin.pdf. Accessed on August 3, 2013
- Hadzijusufovica E, Petera B, Gleixner KV, et al. (2010). H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells. Exp Hematol 38:896–907
- International System for Human Cytogenetic Nomenclature (ISCN). (1985). Report of the standing committee on human cytogenetic nomenclature. Birth Defects Orig Artic Ser 21:1–117
- Kalina I, Ondrussekova A, Konecna H. (1990). Relation of the occurrence of chromosome aberrations in human peripheral lymphocytes to the cell cycle. Cas Lek Cesk 129:23–25
- Kirsch-Volders M, Sofuni T, Aardemac M, et al. (2003). Report from the in vitro micronucleus assay working group. Mutat Res 540:153–163
- Kocaman AY, Topaktaş M. (2007). In vitro evaluation of the genotoxicity of acetamiprid in human peripheral blood lymphocytes. Environ Mol Mutagen 48:483–490
- Lopez Nigro MM, Palermo AM, Mudry MD, Carballo MA. (2003). Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol In Vitro 17:35–40
- Mace ML Jr, Daskal Y, Wray W. (1978). Scanning-electron microscopy of chromosome aberrations. Mutat Res 52:199–206
- Organisation for Economic Co-operation and Development (OECD). (2005). OECD Environment, Health and Safety Publications, Chapter 2: Existing Genotoxicity Assays. Available from: http://www.oecd.org/chemicalsafety/testing/34446120.pdf. Accessed on August 1, 2013
- Perry PE, Thompson EJ. (1984). The methodology of sister chromatid exchanges. In: Kilbey BJ, Legator M, Nichols W, Ramel C, eds. Handbook of mutagenicity test procedures. Amsterdam: Elsevier Science, 495–529
- Poddar S, Talukder G, Sharma A. (2004). Chromosome damage induced by ferric chloride in human peripherallymphocytes. Int J Hum Genet 4:261–264
- Rothfuss A, Schutz P, Bochum S, et al. (2000). Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390–394
- Seligmann IC, Lima PD, Cardoso PC, et al. (2003). The anticancer homeopathic composite “Canova Method” is not genotoxic for human lymphocytes in vitro. Genet Mol Res 2:223–228
- Simons FER. (2003). Antihistamines. In: Middleton E Jr, Reed CE, Ellis EF, et al., eds. Allergy principles and practice. Philedelphia: Mosby Inc, 834–870
- Snyder RD, Green JW. (2001). A review of the genotoxicity of marketed pharmaceuticals. Mutat Res 488:151–169
- Soule BP, Simone NL, DeGraff WG, et al. (2010). Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines. Radiat Oncol 5:1–12
- Speit G, Haupter S. (1985). On the mechanism of differantial giemsa staining of BrdU-substituted chromosomes. Hum Genet 70:126–129
- Titenko-Holland N, Windham G, Kolachana P, et al. (1997). Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: a study of malathion-exposed workers. Mutat Res 388:85–95